Literature DB >> 30225223

The inflammation influence on corneal surface after frontalis suspension surgery.

Kang Li1, Xin-Chun Zhang2, Xian-Xian Cai1, Ya-Dan Quan1, Rong Lu1.   

Abstract

AIM: To study the influence of frontalis muscle flap suspension on ocular surface by analyzing the clinical features and inflammatory cytokines.
METHODS: A prospective, observational case series. Thirty-one eyes of 25 patients with severe congenital blepharoptosis who underwent frontalis muscle flap suspension surgery with at least 6mo of follow-up were included in the study. The main outcome measures were margin reflex distance 1 (MRD1), degree of lagophthalmos, ocular surface disease index (OSDI), fluorescein staining (Fl), tear break-up time (BUT), Schirmer I test, and inflammatory cytokine assay.
RESULTS: The degrees of lagophthalmos significantly increased after surgery. The OSDI scores significantly increased 1wk postoperatively and then decreased 4wk after operation. The Fl scores reflected corneal epithelial defects in sixteen patients at early stage postoperatively. The BUT and Schirmer I test values remained stable and did not show change compared to those before surgery. The inflammatory cytokines in conjunctival epithelial cells (including IL-1β, IL-6, IL-8, TNF-α, and IL-17A) significantly increased 1wk after the surgery (P<0.001), then returned to the normal level at 24wk postoperatively. The levels of inflammatory cytokine IL-1β, IL-6, IL-8, TNF-α, and IL-17A elevated significantly and were positively correlated with OSDI and Fl scores.
CONCLUSION: Frontalis muscle flap suspension surgery results in lagophthalmos in early period of post-operation and relieved after months. The elevation of inflammatory cytokines level may participate in the occurrence of corneal epithelial defects at the early postoperative stage.

Entities:  

Keywords:  congenital blepharoptosis; corneal epithelial defects; frontalis muscle flap suspension; inflammation

Year:  2018        PMID: 30225223      PMCID: PMC6133894          DOI: 10.18240/ijo.2018.09.10

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  40 in total

1.  Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes.

Authors:  F Brignole; P J Pisella; M Goldschild; M De Saint Jean; A Goguel; C Baudouin
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-05       Impact factor: 4.799

2.  Functional indications for upper eyelid ptosis and blepharoplasty surgery: a report by the American Academy of Ophthalmology.

Authors:  Kenneth V Cahill; Elizabeth A Bradley; Dale R Meyer; Philip L Custer; David E Holck; Marcus M Marcet; Louise A Mawn
Journal:  Ophthalmology       Date:  2011-10-22       Impact factor: 12.079

3.  Intra-eyebrow frontalis suspension using inverted Y-shaped short autogenous fascia lata for blepharoptosis with poor levator function.

Authors:  Yusuke Shimizu; Tomohisa Nagasao; Hirokazu Shido; Takako Fujii; Tatsuya Kato; Marie Aoki; Keiko Takada; Kazuo Kishi
Journal:  J Plast Reconstr Aesthet Surg       Date:  2014-09-06       Impact factor: 2.740

4.  Long-term tear volume changes after blepharoptosis surgery and blepharoplasty.

Authors:  Akihide Watanabe; Dinesh Selva; Hirohiko Kakizaki; Yutaro Oka; Norihiko Yokoi; Koichi Wakimasu; Naoko Kimura; Shigeru Kinoshita
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-25       Impact factor: 4.799

5.  Frontalis muscle flap advancement for correction of blepharoptosis.

Authors:  S H Goldey; H I Baylis; R A Goldberg; N Shorr
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2000-03       Impact factor: 1.746

6.  Autoantibodies contribute to the immunopathogenesis of experimental dry eye disease.

Authors:  Michael E Stern; Chris S Schaumburg; Karyn F Siemasko; Jianping Gao; Larry A Wheeler; Devin A Grupe; Cintia S De Paiva; Virginia L Calder; Margarita Calonge; Jerry Y Niederkorn; Stephen C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-24       Impact factor: 4.799

7.  Effects of upper eyelid blepharoplasty on ocular surface sensation and tear production.

Authors:  Hans H Kim; Cintia S De Paiva; Michael T Yen
Journal:  Can J Ophthalmol       Date:  2007-10       Impact factor: 1.882

Review 8.  Rationale for anti-inflammatory therapy in dry eye syndrome.

Authors:  C S de Paiva; S C Pflugfelder
Journal:  Arq Bras Oftalmol       Date:  2008 Nov-Dec       Impact factor: 0.872

9.  Frontalis suspension with an expanded polytetrafluoroethylene sheet for congenital ptosis repair.

Authors:  Kenichi Kokubo; Nobutada Katori; Kengo Hayashi; Kenichiro Kasai; Taro Kamisasanuki; Kentaro Sueoka; Jiro Maegawa
Journal:  J Plast Reconstr Aesthet Surg       Date:  2016-02-02       Impact factor: 2.740

10.  Cosmetic and functional outcomes of frontalis suspension surgery using autologous fascia lata or silicone rods in pediatric congenital ptosis.

Authors:  Hsi-Wei Chung; Lay Leng Seah
Journal:  Clin Ophthalmol       Date:  2016-09-16
View more
  3 in total

1.  Phenotype, genotype, and management of congenital fibrosis of extraocular muscles type 1 in 16 Chinese families.

Authors:  Moxin Chen; Rui Huang; Yingjie Zhang; Deyi Jasmine Zhu; Qin Shu; Pengcheng Xun; Jing Zhang; Ping Gu; Lin Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-09-23       Impact factor: 3.535

2.  Treatment of Severe Ptosis by Conjoint Fascial Sheath Suspension.

Authors:  Pengfei Sang; Mingsong Fang; Xuan Li; Chang Liu; Qingchun Xi
Journal:  Biomed Res Int       Date:  2021-11-19       Impact factor: 3.411

3.  Changes of Dry Eye Related Markers and Tear Inflammatory Cytokines After Upper Blepharoplasty.

Authors:  Songjiao Zhao; Nan Song; Lan Gong
Journal:  Front Med (Lausanne)       Date:  2021-12-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.